Metachromatic Leukodystrophy (MLD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Metachromatic Leukodystrophy (MLD) Marketed and Pipeline Drugs Report Overview
Metachromatic leukodystrophy (MLD), also known as globoid cell leukodystrophy (GCL), is a rare hereditary disease or lysosomal storage disease characterized by the accumulation of fats called sulfatides. This causes the destruction of the protective fatty layer surrounding the nerves in both the central nervous system (CNS) and the peripheral nervous system (PNS).
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
The Metachromatic Leukodystrophy (MLD) marketed and pipeline drugs market research report includes an assessment of the disease epidemiology, leading marketed products with sales forecast, pricing and reimbursement, and late-to-mid-stage pipeline products with Phase Transition Success Rate (PTSR), and Likelihood of Approval (LoA) for MLD. The report also analyzes the clinical and commercial landscapes of Metachromatic Leukodystrophy, as well as an assessment of deals, future market catalysts, key market players, and the future competitive environment.
Key Mechanisms of Action (Pipeline) | · Enzyme Activators
· Enzyme Replacement |
Key Molecule Types (Pipeline) | · Biologics
· Small Molecules · Oligonucleotides |
Top Sponsors (Marketed and Pipeline Drugs) | · Orchard Therapeutics
· Magenta Therapeutics · Shire Pharmaceutical Inc. · French National Institute of Health and Medical Research · Memorial Sloan Kettering Cancer Centre |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
MLD Pipeline Drugs Market Segmentation by Mechanisms of Action
The drugs under development for MLD are mostly enzyme activators followed by enzyme replacement.
MLD Pipeline Drugs Market Analysis by Mechanisms of Action, 2023 (%)
Buy the Full Report to Know More about the MoA of MLD Pipeline Drugs
MLD Pipeline Drugs Market Segmentation by Molecule Types
Most pipeline drugs for Metachromatic Leukodystrophy are biologics followed by small molecules and oligonucleotides.
MLD Pipeline Drugs Market Analysis by Molecule Types, 2023 (%)
Buy the Full Report to Know More about the Molecule Types of MLD Pipeline Drugs
MLD Marketed and Pipeline Drugs Market – Competitive Landscape
Some of the top sponsors in the MLD marketed and pipeline drugs market are Orchard Therapeutics, Magenta Therapeutics, Shire Pharmaceutical Inc., French National Institute of Health and Medical Research, and Memorial Sloan Kettering Cancer Centre. In 2023, the highest number of trials have been conducted by Orchard Therapeutics, Magenta Therapeutics, and Shire Pharma.
MLD Marketed and Pipeline Drugs Market Analysis by Sponsors, 2023 (%)
Buy Full Report for More Sponsor Insights into the MLD Marketed and Pipeline Drugs Market Download A Free Report Sample
Segments Covered in the Report
MLD Pipeline Drugs Mechanisms of Action Outlook (Number of Drugs, 2023)
- Enzyme Activators
- Enzyme Replacement
MLD Pipeline Drugs Molecule Types Outlook (Number of Drugs, 2023)
- Biologics
- Small Molecules
- Oligonucleotides
Scope
Components of the report include:
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Breakdown by Mechanism of Action, Route of Administration
- Product Profiles with Sales Forecast
- Pricing and Reimbursement Assessment
- Annual Therapy Cost
- Time to Pricing and Time to Reimbursement
- Pipeline Assessment
- Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Late-to-mid-stage Pipeline Drugs
- Phase Transition Success Rate and Likelihood of Approval
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
- Enrolment Analytics, Site Analytics, Feasibility Analysis
- Deals Landscape
- Mergers, Acquisitions, and Strategic Alliances by Region
- Overview of Recent Deals
- Commercial Assessment
- Key Market Players
- Future Market Catalysts
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the MLD market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global MLD market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Table of Contents
Frequently asked questions
-
Which is the leading MoA for MLD pipeline drugs?
In 2023, most of the MLD pipeline drugs are enzyme activators.
-
Which is the leading molecule type for MLD pipeline drugs?
In 2023, most of the pipeline drugs for MLD are biologics.
-
Who are the top sponsors for the MLD marketed and pipeline drugs market?
Some of the top sponsors in the MLD marketed and pipeline drugs market are Orchard Therapeutics, Magenta Therapeutics, Shire Pharmaceutical Inc., French National Institute of Health and Medical Research, and Memorial Sloan Kettering Cancer Centre.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.